logo
appgoogle
EquityWireAnalyst Concall: Max Health says settled tariff dispute with insurance cos
Analyst Concall

Max Health says settled tariff dispute with insurance cos

This story was originally published at 13:44 IST on 17 November 2025
Register to read our real-time news.

Informist, Monday, Nov. 17, 2025

 

Please click here to read all liners published on this story
--Max Health: International patients contributed 9% to total sales in H1 
--CONTEXT: Comments by Max Healthcare's mgmt in post-earnings analyst call
--Max Health: Settled tariff issues with some insurance cos 
--Max Health: Ramping up occupancy in new hospitals in Dwarka, Noida 
--Max Health: Avg revenue per occupied bed at existing hospitals improving
--Max Health: Share of self-paying patients increased in Q2 
--Max Health:Impact of central govt health scheme tariff hike to reflect FY27 

 

By Narayana Krishna and Eshitva Prakash


HYDERABAD/MUMBAI – Max Healthcare Institute Ltd. Monday said it has settled the tariff dispute with insurance companies and the company is accepting patients with insurance coverage and cashless treatment option. The issue with at least four major insurance companies was settled and cashless treatment was back on track, the company's management said in a post-earnings analyst conference call. 


In September, Max Healthcare and some insurance companies engaged in a tariff tussle, leading to the suspension of cashless treatment at its network hospitals for policyholders. Insurance companies such as Tata AIG, Star Health, and Niva Bupa among others, were involved in the tussle, demanding further rate cuts in various treatments, even though there was a two-year tariff agreement between insurers and Max Healthcare in place.


After the dispute, the revenue from the insurance segment fell to 33.8% of the total revenue in the September quarter compared with 37.2% a year ago. Max Healthcare management said the share of patients paying on their own in cash increased to 35.5% of the total sales from 35.3% a year ago. The hospital network company said the international patient's share of total sales improved to 9.2% from 8.9% a year ago.


For the September quarter, Max Healthcare reported a consolidated net profit of INR 4.91 billion, up 74% on year, led by a deferred tax write-back of INR 555.60 million. The company's consolidated revenue was at INR 21.35 billion, up 25% on year.

 

"With regard to insurance renewals, there was an impasse with certain layers leading to temporary shortage, stopping of cashless facilities. The same has been resolved," Max Healthcare management said.


The management said the issues on the existing tariff were settled and there is a likely agreement to sort out the future issues with three major companies along with other small insurance companies.


Max Healthcare management said it is ramping up bed capacity and occupancy at its new hospitals at Dwarka and Noida in the National Capital Region. At Dwarka, 25% of planned capacity is operational and occupancy is of around 80%. Hospitals at Lucknow and Nagpur were also doing better, the company said, refusing to provide hospital-wise performance details.


The company said the growth in average revenue per occupied bed in existing hospitals is improving, though it is seen lower due to share of new hospitals increasing. Excluding the new hospitals and acquired hospitals, the average revenue per occupied bed growth was at 7% on year, Max Healthcare said.


Max Healthcare is expecting full impact of recent revision of the Central Government Health Scheme rates and addition of new categories to benefit the overall revenues. The impact of the new additions like super specialty category may reflect in FY27, the management said.


At 1321 IST, Max Healthcare shares traded at INR 1,119.90 on the National Stock Exchange, up 1.5% from their previous close.  End

 

IST, or Indian Standard Time, is five-and-a-half hours ahead of GMT

 

Edited by Akul Nishant Akhoury

 

For users of real-time market data terminals, Informist news is available exclusively on the NSE Cogencis WorkStation.

 

Cogencis news is now Informist news. This follows the acquisition of Cogencis Information Services Ltd by NSE Data & Analytics Ltd, a 100% subsidiary of the National Stock Exchange of India Ltd. As a part of the transaction, the news department of Cogencis has been sold to Informist Media Pvt Ltd.

 

Informist Media Tel +91 (11) 4220-1000

Send comments to feedback@informistmedia.com

 

© Informist Media Pvt. Ltd. 2025. All rights reserved.

To read more please subscribe

Share this Story:

twitterlinkedinwhatsappmaillinkprint

Related Stories

Premium Stories

Subscribe